22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here

  • Home
  • About Us
    • Our Company
    • Our Leadership Team
    • Board of Directors
  • Reduced Nicotine Tobacco
    • VLN®
    • Clinical Studies & Commentaries
  • Hemp/Cannabis Innovation
    • GVB Biopharma
  • Hops Research
  • News
  • Investors
    • Overview
    • New Investor / Latest Resources
    • Events
    • News
    • Stock Data
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
    • Annual Reports
    • FAQs
  • Contact Us

Press Releases

Investors

Investors

  • Overview
  • New Investor / Latest Resources
  • Events
  • News
    • Press Releases
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Trades
  • SEC Filings
  • Analyst Coverage
  • Corporate Governance
  • Annual Reports
  • FAQs
  • News

  • Press Releases
Jun 11, 2014 1:40pm EDT

U.S. Patent Allowed For 22nd Century Group’s Technology to Regulate Nicotine Levels in Tobacco

May 29, 2014 7:15am EDT

22nd Century Group Signs Letter of Intent With European Factory For Production of Nicotine-Free Tobacco Cigarettes in Europe

May 28, 2014 7:15am EDT

22nd Century Group to Present at Institutional Investor Conference as Part of National Road Show

May 15, 2014 8:22am EDT

22nd Century Group Appoints General Counsel

May 02, 2014 11:30am EDT

22nd Century Group Reports First Quarter 2014 Financial Results

Apr 21, 2014 6:25am EDT

22nd Century Group Files $45 Million Shelf Registration and Provides Business Update

Apr 01, 2014 8:12am EDT

22nd Century Group Eliminates $7.7 Million of Warrant Liability

Mar 10, 2014 7:44am EDT

22nd Century Group Subsidiary Goodrich Tobacco Company Granted Federal Permit to Manufacture Tobacco Products

Mar 06, 2014 5:30pm EST

22nd Century Group Approved to List Common Stock on NYSE MKT

Feb 11, 2014 7:20am EST

22nd Century Group Files For NYSE MKT Listing and NASDAQ Capital Market Listing

RSS
  • Prev
    • 1...
    • 29
    • 30
    • 31
    • 32
    • 33
    • 34
    • 35
    • 36
    • 37
    • 38
    Next
    • Email Alerts
    • Contact
    • RSS News Feed
    © 2023 22nd Century Group, Inc. All Rights Reserved.
    Privacy Policy / CCPA Disclaimer Sitemap